{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:38:22Z","timestamp":1779143902836,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.otoeng.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T13:01:10Z","timestamp":1658408470000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Faustino","family":"N\u00fa\u00f1ez-Batalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"J\u00e1udenes-Casaub\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Sequ\u00ed-Canet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Vivanco-Allende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Zubicaray-Ugarteche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otoeng.2022.07.002_bib0005","series-title":"Ototoxicity","author":"Roland","year":"2004"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0010","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pbc.24236","article-title":"The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy","volume":"60","author":"Abujamra","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0020","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0025","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ijporl.2007.06.021","article-title":"Recovery from cisplatin-induced ototoxicity: a case report and review","volume":"71","author":"Truong","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb00277.x","article-title":"Global problem of drug-induced hearing loss","volume":"884","author":"Arslan","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7874\/jao.2017.00360","article-title":"Ototoxicity: a challenge in diagnosis and treatment","volume":"22","author":"Ganesan","year":"2018","journal-title":"J Audiol Otol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer","volume":"29","author":"Coradini","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12070-011-0151-8","article-title":"Ototoxicity: the hidden menace","volume":"63","author":"Bisht","year":"2011","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","article-title":"Ototoxicity of loop diuretics","volume":"26","author":"Rybak","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1200\/JCO.18.01358","article-title":"Cognitive implications of ototoxicity in pediatric patients with embryonal brain tumors","volume":"37","author":"Olivier","year":"2019","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0065","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S1470-2045(18)30858-1","article-title":"Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium","volume":"20","author":"Clemens","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0070","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1632-3475(13)64009-6","article-title":"Ototoxicidad farmacol\u00f3gica","volume":"42","author":"Dulon","year":"2013","journal-title":"EMC - Otorrinolaringolog\u00eda"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14740338.5.3.383","article-title":"Understanding drug ototoxicity: molecular insights for prevention and clinical management","volume":"5","author":"Yorgason","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/000348948109000208","article-title":"Nature of blood-labyrinth barrier in experimental conditions","volume":"90","author":"Juhn","year":"1981","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0090","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1359-6446(05)03574-9","article-title":"Local inner-ear drug delivery and pharmacokinetics","volume":"10","author":"Salt","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/mr.51.3.341-350.1987","article-title":"Mechanism of bactericidal action of aminoglycosides","volume":"51","author":"Davis","year":"1987","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/00016488809106429","article-title":"Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the guinea pig","volume":"106","author":"Dulon","year":"1988","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/jn.00160.2004","article-title":"Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla","volume":"93","author":"Hirvonen","year":"2005","journal-title":"J Neurophysiol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jmedgenet-2014-102753","article-title":"Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis","volume":"52","author":"Jing","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0115","first-page":"173","article-title":"Ototoxicity in vitro: effects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin, neamine","volume":"73","author":"Kotecha","year":"1994","journal-title":"spermine and poly-l-lysine. Hearing Research"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/jn.00160.2004","article-title":"Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla","volume":"93","author":"Hirvonen","year":"2005","journal-title":"J Neurophysiol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033548","article-title":"Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies","volume":"9","author":"Kros","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOO.0b013e3282ef772d","article-title":"Aminoglycoside ototoxicity","volume":"15","author":"Rizzi","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/17425255.2011.614231","article-title":"In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem","volume":"7","author":"Yorgason","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0140","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/pgs-2017-0125","article-title":"Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin","volume":"18","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1124\/mol.104.001198","article-title":"The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells","volume":"66","author":"Holzer","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0150","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1523\/JNEUROSCI.1544-10.2010","article-title":"Role of the copper transporter, CTR1, in platinum-induced ototoxicity","volume":"30","author":"More","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5955(99)00177-X","article-title":"Apoptotic death of hair cells in mammalian vestibular sensory epithelia","volume":"139","author":"Forge","year":"2000","journal-title":"Hear Res"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/03655230310016799","article-title":"Signaling pathway for apoptosis of vestibular hair cells of mice due to aminoglycosides","volume":"124","author":"Lee","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0385-8146(03)00049-X","article-title":"Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs","volume":"30","author":"Watanabe","year":"2003","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0170","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3766\/jaaa.25.8.6","article-title":"Challenges in ototoxicity monitoring in the pediatric oncology population","volume":"25","author":"Bass","year":"2014","journal-title":"J Am Acad Audiol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210646","article-title":"A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood c\u00e1ncer patients treated with platinum-based chemotherapy","volume":"14","author":"Clemens","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21875","article-title":"Ototoxicity in children treated for osteosarcoma","volume":"52","author":"Lewis","year":"2009","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (cochleotoxicity) classifications: a review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int J Audiol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0039-1684044","article-title":"Pediatric ototoxicity: current trends and management","volume":"40","author":"Fligor","year":"2019","journal-title":"Semin Hear"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anpedi.2020.08.008","article-title":"Ototoxicity in cancer survivors: experience and proposal of a surveillance protocol","volume":"95","author":"S\u00e1nchez-Canteli","year":"2021","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.otorri.2015.05.007","article-title":"Recomendaciones CODEPEH 2014: detecci\u00f3n precoz de la hipoacusia diferida, diagn\u00f3stico audiol\u00f3gico y adaptaci\u00f3n audioprot\u00e9sica y atenci\u00f3n temprana","volume":"67","author":"N\u00fa\u00f1ez-Batalla","year":"2016","journal-title":"Acta Otorrinolaringol Esp."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","article-title":"Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the Children\u2019s Oncology Group","volume":"35","author":"Knight","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0210","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1080\/14992027.2017.1417644","article-title":"Clinical trials, ototoxicity grading scales, and the audiologist\u2019s role in therapeutic decision making","volume":"57","author":"King","year":"2018","journal-title":"Int J Audiol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0215","article-title":"A protective mechanism against antibiotic-induced ototoxicity: role of prestin","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0220","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.amjoto.2018.07.007","article-title":"Utilizing prestin as a predictive marker for the early detection of outer hair cell damage","volume":"39","author":"Dogan","year":"2018","journal-title":"Am J Otolaryngol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/ijmbs.ijmbs_4_18","article-title":"Prestin, otolin-1 regulation, and human 8-oxoG DNA glycosylase 1 gene polymorphisms in noise-induced hearing loss","volume":"10","author":"Hana","year":"2018","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MAO.0000000000002466","article-title":"Inner ear proteins as potential biomarkers","volume":"41","author":"Mulry","year":"2020","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0235","doi-asserted-by":"crossref","first-page":"E2836","DOI":"10.3390\/ijms19092836","article-title":"Circulating serum miRNA-205 as a diagnostic biomarker for ototoxicity in mice treated with aminoglycoside antibiotics","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0240","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ijporl.2015.05.036","article-title":"Gentamicin extended interval regimen and ototoxicity in neonates","volume":"79","author":"El-Barbary","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s10038-018-0544-6","article-title":"The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence","volume":"64","author":"Igumnova","year":"2019","journal-title":"J Hum Genet."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijporl.2019.02.002","article-title":"Genetic susceptibility to aminoglycoside ototoxicity","volume":"120","author":"Nguyen","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0255","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMc0806396","article-title":"Prevalence of mitocondrial 1555A\u2192G mutation in European children","volume":"360","author":"Bitner-Glindzicz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0260","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0001-6519(02)78349-0","article-title":"Incidence of A1555G mutations in the mitochondrial DNA and 35delG in the GJB2 gene (connexin-26) in families with late onset non-syndromic sensorineural hearing loss from Cantabria","volume":"53","author":"Gallo-Ter\u00e1n","year":"2002","journal-title":"Acta Otorrinolaringol Esp."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0265","first-page":"156","article-title":"Distortion-product otoacoustic emissions testing in neonates treated with an aminoglycoside in a neonatal intensive care unit","volume":"94","author":"Vital","year":"2015","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1158\/1078-0432.CCR-17-2810","article-title":"Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients","volume":"24","author":"Dr\u00f6gem\u00f6ller","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0275","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41397-019-0113-1","article-title":"Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study","volume":"20","author":"Clemens","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0280","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-18-2244","article-title":"Genetic and modifiable risk factors contributing to cisplatin-induced toxicities","volume":"25","author":"Trendowski","year":"2019","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00109-020-01921-y","article-title":"G\u00e9czi GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs","volume":"98","author":"Budai","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0290","series-title":"Hearing Loss: Mechanisms, Prevention and Cure, Advances in Experimental Medicine and Biology 1130","article-title":"Protection of hair cells from ototoxic drug-induced hearing loss","author":"Guo","year":"2019"},{"issue":"Suppl 4","key":"10.1016\/j.otoeng.2022.07.002_bib0295","first-page":"S76","article-title":"Current practice of ototoxicity management across the United Kingdom (UK)","volume":"57","author":"Maru","year":"2018","journal-title":"Int J Audiol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0300","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00106-019-0663-1","article-title":"Pharmacological intervention in the field of ototoxicity","volume":"67","author":"Laurell","year":"2019","journal-title":"HNO"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0305","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41401-019-0342-5","article-title":"Mechanisms and pharmacokinetic\/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin","volume":"41","author":"Yao","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0310","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41598-019-38634-3","article-title":"Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use","volume":"9","author":"Ishikawa","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0315","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/jacs.9b12420","article-title":"Chemical modifications reduce auditory cell damage induced by aminoglycoside antibiotics","volume":"142","author":"Zada","year":"2020","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0320","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fncel.2019.00416","article-title":"Gentamicin affects the bioenergetics of isolated mitochondria and collapses the mitochondrial membrane potential in cochlear sensory hair cells","volume":"13","author":"O\u2019Reilly","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0325","first-page":"162","article-title":"Otoprotectants: from research to clinical application","volume":"40","author":"Le Prell","year":"2019","journal-title":"SeminHear"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0330","article-title":"Combination of antioxidants and NFAT (nuclear factor of activated T cells) inhibitor protects auditory hair cells from ototoxic insult","volume":"22","author":"Sekulic-Jablanovic","year":"2019","journal-title":"J Neurochem."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0335","article-title":"Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents","volume":"136","author":"Dos Santos","year":"2020","journal-title":"ChemToxicol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0340","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/cancers12051266","article-title":"Assessment and management of platinum-related ototoxicity in children treated for cancer","volume":"12","author":"Romano","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0345","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fncel.2017.00268","article-title":"Magnetic nanoparticle mediated steroid delivery mitigates cisplatin induced hearing loss","volume":"11","author":"Ramaswamy","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0350","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMc053428","article-title":"Aspirin to prevent gentamicin-induced hearing loss","volume":"354","author":"Sha","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2017.09.033","article-title":"COAST (Cisplatin ototoxicity attenuated by aspirin trial): a phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss","volume":"87","author":"Crabb","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0360","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/coa.13457","article-title":"The efficacy of statins as otoprotective agents: a systematic review","volume":"45","author":"Prayuenyong","year":"2020","journal-title":"Clin Otolaryngol."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0365","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00405-020-06003-w","article-title":"Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?","volume":"277","author":"Waissbluth","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0370","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fncel.2017.00280","article-title":"Hydrogen inhalation protects against ototoxicity induced by intravenous cisplatin in the guinea pig","volume":"11","author":"Fransson","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.otoeng.2022.07.002_bib0375","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033548","article-title":"Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies","volume":"9","author":"Kros","year":"2019","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.otoeng.2022.07.002_bib0380","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","volume":"5","author":"van As","year":"2019","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573522000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573522000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:46:40Z","timestamp":1761878800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573522000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2173573522000746"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2022.07.002","relation":{},"ISSN":["2173-5735"],"issn-type":[{"value":"2173-5735","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}